Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Se Hoon Kim

Showing results (431-440 of 481) with videos related to

Pageof 49
Sort By:
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|November 13, 2012
Changes in the biological characteristics of glioma cancer stem cells after serial in vivo subtransplantationGa-Yeong Shin, Jin-Kyoung Shim, Ji-Hyun Lee, et al.
Clinical Nuclear Medicine|July 22, 2022
11 C-Acetate PET/CT Detects Reactive Astrogliosis Helping Glioma ClassificationDongwoo Kim, Joong Hyun Chun, Ju Hyeon Yi, et al.
Journal of Neurosurgery|December 31, 2021
Patterns of recurrence according to the extent of resection in patients with IDH-wild-type glioblastoma: a retrospective studyJihwan Yoo, Seon-Jin Yoon, Kyung Hwan Kim, et al.
Medicine|July 7, 2017
Long-term outcomes of concomitant chemoradiotherapy with temozolomide for newly diagnosed glioblastoma patients: A single-center analysisTae Hoon Roh, Hun Ho Park, Seok-Gu Kang, et al.
Nature Medicine|September 19, 2018
BRAF somatic mutation contributes to intrinsic epileptogenicity in pediatric brain tumorsHyun Yong Koh, Se Hoon Kim, Jaeson Jang, et al.
Nature Medicine|March 24, 2015
Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsyJae Seok Lim, Woo-il Kim, Hoon-Chul Kang, et al.
Discover Oncology|June 6, 2023
Efficacy and safety of metformin plus low-dose temozolomide in patients with recurrent or refractory glioblastoma: a randomized, prospective, multicenter, double-blind, controlled, phase 2 trial (KNOG-1501 study)Wan-Soo Yoon, Jong Hee Chang, Jeong Hoon Kim, et al.
Annals of Clinical and Translational Neurology|July 30, 2019
p75 and neural cell adhesion molecule 1 can identify pathologic Schwann cells in peripheral neuropathiesYoung Hee Kim, Young Hye Kim, Yoon Kyung Shin, et al.
International Journal of Oncology|August 8, 2013
Isolation of mesenchymal stem-like cells in meningioma specimensHyo-Yeol Lim, Kyung Min Kim, Bo Kyung Kim, et al.
Oncotarget|September 2, 2016
Inhibiting stemness and invasive properties of glioblastoma tumorsphere by combined treatment with temozolomide and a newly designed biguanide (HL156A)Junjeong Choi, Ji-Hyun Lee, Ilkyoo Koh, et al.
Pageof 49

Showing results (431-440 of 481) with videos related to

Sort By:
Pageof 49
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|November 13, 2012
Changes in the biological characteristics of glioma cancer stem cells after serial in vivo subtransplantationGa-Yeong Shin, Jin-Kyoung Shim, Ji-Hyun Lee, et al.
Clinical Nuclear Medicine|July 22, 2022
11 C-Acetate PET/CT Detects Reactive Astrogliosis Helping Glioma ClassificationDongwoo Kim, Joong Hyun Chun, Ju Hyeon Yi, et al.
Journal of Neurosurgery|December 31, 2021
Patterns of recurrence according to the extent of resection in patients with IDH-wild-type glioblastoma: a retrospective studyJihwan Yoo, Seon-Jin Yoon, Kyung Hwan Kim, et al.
Medicine|July 7, 2017
Long-term outcomes of concomitant chemoradiotherapy with temozolomide for newly diagnosed glioblastoma patients: A single-center analysisTae Hoon Roh, Hun Ho Park, Seok-Gu Kang, et al.
Nature Medicine|September 19, 2018
BRAF somatic mutation contributes to intrinsic epileptogenicity in pediatric brain tumorsHyun Yong Koh, Se Hoon Kim, Jaeson Jang, et al.
Nature Medicine|March 24, 2015
Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsyJae Seok Lim, Woo-il Kim, Hoon-Chul Kang, et al.
Discover Oncology|June 6, 2023
Efficacy and safety of metformin plus low-dose temozolomide in patients with recurrent or refractory glioblastoma: a randomized, prospective, multicenter, double-blind, controlled, phase 2 trial (KNOG-1501 study)Wan-Soo Yoon, Jong Hee Chang, Jeong Hoon Kim, et al.
Annals of Clinical and Translational Neurology|July 30, 2019
p75 and neural cell adhesion molecule 1 can identify pathologic Schwann cells in peripheral neuropathiesYoung Hee Kim, Young Hye Kim, Yoon Kyung Shin, et al.
International Journal of Oncology|August 8, 2013
Isolation of mesenchymal stem-like cells in meningioma specimensHyo-Yeol Lim, Kyung Min Kim, Bo Kyung Kim, et al.
Oncotarget|September 2, 2016
Inhibiting stemness and invasive properties of glioblastoma tumorsphere by combined treatment with temozolomide and a newly designed biguanide (HL156A)Junjeong Choi, Ji-Hyun Lee, Ilkyoo Koh, et al.
Pageof 49